Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-23-005616

CVP, Critical Care sold 75,600 shares at $88.94 ($6,724,234)

  • CVP, Critical Care acquired 80,308 shares (option exercise)
  • CVP, Critical Care gave up 3,530 shares (to pay taxes)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Szyman Catherine M. · CVP, Critical Care

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2023-05-07 Exercise or conversion : show line 1 in the form 10b5-1 +4,708 32,060.78 D
2023-05-07 Shares withheld for taxes : show line 2 in the form 10b5-1 −2,154 $88.74 $191,146 29,906.78 D
2023-05-08 Shares withheld for taxes : show line 3 in the form 10b5-1 −1,376 $88.74 $122,106 28,530.78 D
2023-05-09 Exercise or conversion : show line 4 in the form 10b5-1 +75,600 $35.20 $2,660,871 104,130.78 D
2023-05-09 Sale : show line 5 in the form 10b5-1 −75,600 $88.94 $6,724,234 28,530.78 D
Open-market sales · 75,600 sh · avg $88.94 · $6,724,234

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-05-07 Exercise or conversion : show line 6 in the form 10b5-1 Performance Rights −4,708 2027-05-06 4,708 1,292 D
2023-05-09 Exercise or conversion : show line 7 in the form 10b5-1 Employee Stock Option (Right to Acquire) −75,600 $35.20 2023-05-11 75,600 0 D
Loading xslF345X04/doc4.xml…